v3.10.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating Expenses:        
Research and development expenses $ 188,435 $ 27,797 $ 320,838 $ 130,136
General and administrative expenses 160,173 160,737 507,727 408,656
Equity-based compensation 3,467,491 73,882 5,068,514 134,700
Total Operating Expenses 3,816,099 262,416 5,897,079 673,492
Loss From Operations (3,816,099) (262,416) (5,897,079) (673,492)
Other Income (Expense)        
Interest income 367
Gain (loss) on debt extinguishments (3,496,743) (3,484,502)
Interest expense and financing charges (878,082) (30,210) (980,649) (62,339)
Total other income (expense) (4,374,825) (30,210) (4,465,151) (61,972)
Loss Before Provision For Income Taxes (8,190,924) (292,626) (10,362,230) (735,464)
Provision for income taxes
Net Loss $ (8,190,924) $ (292,626) $ (10,362,230) $ (735,464)
Net loss per share, basic and diluted $ (1.48) $ (0.09) $ (2.51) $ (0.23)
Weighted average shares, basic and diluted 5,546,749 3,267,388 4,132,299 3,268,006

Source